Recent News and Updates
Dr. Keith Block’s Editorial in September 2016 – Integrative Cancer Therapies
Dr Lemmo’s case report is a leading story in this months Integrative Cancer Therapies journal. It is an honour to have Dr. Keith Block, a respected and pioneering oncologist, comment on our Raloxifene Anti-Estrogen Withdrawal Effect case which was published online in July 2016. In this issue you will also see the more detailed Editorial by Dr. V. Craig Jordan, also known as the “Father of Tamoxifen”, from MD Anderson Cancer Center regarding this case report and his fascinating insights into how a women’s own estrogen can shrink breast cancer even when followed by hormone treatments such as Tamoxifen and related drugs.
Please see the below link to read Dr. Keith Block’s Editorial.
FARMACIE 7.0 | THE GARDEN OF EDEN – Dinner Event – August 11th
Join us for a special long table dinner on Thursday, August 11 in the Poplar Grove at The UBC Farm. In collaboration with The Juice Truck and Feedlife, we’re creating a true plant-based ‘Garden of Eden’ meal in honour of Eden Elizabeth to benefit Thrive Alive Foundation; a foundation focused on creating access for Canadians to life-enhancing cancer treatments not traditionally covered by the government or most health care plans.
We will enjoy an epic 5 COURSE MEAL curated by a chef team that has been hand picked by Colin Medhurst (co-founder of Feedlife and plant-based chef): Your headliner is Chef Karen McAthy of Blue Heron Cheese who will announce her final lineup this week! Your dinner ticket includes wine pairing by Red Rooster, cocktails by Design to Dine, beer & live entertainment!
Show up in your Thursdays’ finest (aka: farm chic) and expect the venue to completely blow your farm-to-table, garden of eden dreams out of the water.
“Father of Tamoxifen” Dr V. Craig Jordan supports a recent case report by our Dr. Lemmo. There may exist a potential “dark-side” of Tamoxifen-type drugs used in breast cancer and its prevention.
A patient with advanced breast cancer experienced a significant shrinkage of her metastatic disease when stopping the drug Raloxifene (a relative of Tamoxifen). She continues to be in excellent shape without the need of any treatment during the past 16 months. The oncology community is largely not aware of this phenomenon where a drug designed to help with breast cancer may do the exact opposite and feed the disease. Senior scientist and researcher Dr. V. Craig Jordan from the University of Texas MD Anderson Cancer Center wanted to place further attention in this area by writing an editorial on our case. This has been such an incredible honour and we are truly humbled by Dr. Jordan’s supportive comments. Dr. Jordan shares valuable expertise and insights into how the bodies own estrogen can actually shrink breast cancer which may be an explanation for the positive response seen in this case report.
To find out more, the scientific article can be found below.